z-logo
open-access-imgOpen Access
Antibody-drug Conjugates Change the Standard of Care for Both B- and T-cell Non-Hodgkin Lymphoma
Author(s) -
Caron A. Jacobson
Publication year - 2020
Publication title -
˜the œhematologist
Language(s) - English
Resource type - Journals
ISSN - 1551-8779
DOI - 10.1182/hem.v17.1.10157
Subject(s) - antibody drug conjugate , drug , lymphoma , antibody , conjugate , hodgkin lymphoma , b cell lymphoma , medicine , cancer research , monoclonal antibody , pharmacology , immunology , mathematics , mathematical analysis

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here